# Frequency Electronics Inc: overview FEIM · Nasdaq · CIK 39020 · [Technology](/sectors/technology.md) · fiscal year ends Apr 30 Pages: [Overview](/companies/feim.md) · [Financials](/companies/feim/financials.md) · [Filings](/companies/feim/filings.md) · [Insiders](/companies/feim/insiders.md) Latest reported revenue: [$23.5m](/filings/0001185185-26-003983.md) for Q1 FY2027, three months to 2026-07-31, from the 10-Q filed Sep 14, 2026 (XBRL us-gaap:Revenues, accession 0001185185-26-003983). ## Last eight quarters | Line item | Unit | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [15.8](/filings/0001185185-25-002057.md) | [18.9](/filings/0001185185-26-000893.md) | [20.0 d](/filings/0001185185-26-002997.md) | [13.8](/filings/0001185185-26-003983.md) | [17.1](/filings/0001185185-25-002057.md) | [16.9](/filings/0001185185-26-000893.md) | [15.4 d](/filings/0001185185-26-002997.md) | [23.5](/filings/0001185185-26-003983.md) | | Gross margin | % | [48.2%](/filings/0001185185-25-002057.md) | [43.8%](/filings/0001185185-26-000893.md) | [37.5% d](/filings/0001185185-26-002997.md) | [36.8%](/filings/0001185185-26-003983.md) | [38.2%](/filings/0001185185-25-002057.md) | [39.2%](/filings/0001185185-26-000893.md) | [1.0% d](/filings/0001185185-26-002997.md) | [45.8%](/filings/0001185185-26-003983.md) | | Operating margin | % | [16.5%](/filings/0001185185-25-002057.md) | [18.3%](/filings/0001185185-26-000893.md) | [16.4% d](/filings/0001185185-26-002997.md) | [2.6%](/filings/0001185185-26-003983.md) | [10.0%](/filings/0001185185-25-002057.md) | [7.5%](/filings/0001185185-26-000893.md) | [(41.2%) d](/filings/0001185185-26-002997.md) | [22.2%](/filings/0001185185-26-003983.md) | | Net margin | % | [16.8%](/filings/0001185185-26-000893.md) | [81.4%](/filings/0001185185-26-000893.md) | [16.0% d](/filings/0001185185-26-002997.md) | [4.6%](/filings/0001185185-26-003983.md) | [10.5%](/filings/0001185185-26-000893.md) | [9.3%](/filings/0001185185-26-000893.md) | [(31.9%) d](/filings/0001185185-26-002997.md) | [18.0%](/filings/0001185185-26-003983.md) | | Diluted EPS | $ per share | [0.28](/filings/0001185185-25-002057.md) | [1.60](/filings/0001185185-26-000893.md) | not reported | [0.07](/filings/0001185185-26-003983.md) | [0.18](/filings/0001185185-25-002057.md) | [0.16](/filings/0001185185-26-000893.md) | not reported | [0.41](/filings/0001185185-26-003983.md) | | Free cash flow | $m | [3.3 d](/filings/0001185185-25-002057.md) | [(4.0) d](/filings/0001185185-26-000893.md) | [(0.8) d](/filings/0001185185-26-002997.md) | [0.4](/filings/0001185185-26-003983.md) | [(1.1) d](/filings/0001185185-25-002057.md) | [(2.3) d](/filings/0001185185-26-000893.md) | [1.5 d](/filings/0001185185-26-002997.md) | [1.8](/filings/0001185185-26-003983.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-04-30) | FY2023 (2023-04-30) | FY2024 (2024-04-30) | FY2025 (2025-04-30) | FY2026 (2026-04-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [48.3](/filings/0001185185-23-000763.md) | [40.8](/filings/0001185185-24-000753.md) | [55.3](/filings/0001185185-25-000806.md) | [69.8](/filings/0001185185-26-002997.md) | [63.2](/filings/0001185185-26-002997.md) | | Gross margin | % | [17.8%](/filings/0001185185-23-000763.md) | [19.2%](/filings/0001185185-24-000753.md) | [33.6%](/filings/0001185185-25-000806.md) | [43.1%](/filings/0001185185-26-002997.md) | [29.1%](/filings/0001185185-26-002997.md) | | Operating margin | % | [(16.6%)](/filings/0001185185-23-000763.md) | [(11.5%)](/filings/0001185185-24-000753.md) | [9.1%](/filings/0001185185-25-000806.md) | [16.8%](/filings/0001185185-26-002997.md) | [(4.7%)](/filings/0001185185-26-002997.md) | | Net margin | % | [(17.9%)](/filings/0001185185-23-000763.md) | [(13.5%)](/filings/0001185185-24-000753.md) | [10.1%](/filings/0001185185-25-000806.md) | [33.9%](/filings/0001185185-26-002997.md) | [(1.4%)](/filings/0001185185-26-002997.md) | | Diluted EPS | $ per share | not reported | not reported | [0.59](/filings/0001185185-25-000806.md) | [2.46](/filings/0001185185-26-002997.md) | [(0.09)](/filings/0001185185-26-002997.md) | | Free cash flow | $m | [2.2](/filings/0001185185-23-000763.md) | [0.3](/filings/0001185185-24-000753.md) | [7.2](/filings/0001185185-25-000806.md) | [(3.2)](/filings/0001185185-26-002997.md) | [(1.6)](/filings/0001185185-26-002997.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/feim/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Edenbrook Capital, LLC](/funds/1666682.md) | 2026-06-30 | $124.3m | 1,873,810 | | Unchanged | | [Driehaus Capital Management LLC](/funds/938206.md) | 2026-06-30 | $46.9m | 706,207 | | Added +214,306 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $34.3m | 516,548 | | Added +41,670 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $19.4m | 291,902 | | Added +9,461 | | [NEXT CENTURY GROWTH INVESTORS LLC](/funds/1134007.md) | 2026-06-30 | $15.3m | 230,728 | | Added +14,354 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $15.1m | 228,382 | | Reduced −29,020 | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $13.6m | 205,589 | | Reduced −59,092 | | [SEGALL BRYANT & HAMILL, LLC](/funds/1006378.md) | 2026-06-30 | $13.5m | 204,213 | | Reduced −7,902 | | [G2 Investment Partners Management LLC](/funds/1593404.md) | 2026-06-30 | $13.4m | 202,655 | | Added +90,366 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $11.8m | 177,998 | | Added +17,656 | ## Recent filings [All 684 filings](/companies/feim/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-21 | 20:30 ET | [8-K](/filings/0001185185-26-004889.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001185185-26-004889 | | 2026-10-08 | 10:31 ET | [8-K](/filings/0001185185-26-004648.md) | 5.07 Shareholder vote results | 0001185185-26-004648 | | 2026-09-14 | 20:44 ET | [10-Q](/filings/0001185185-26-003983.md) | Quarterly report, period 2026-07-31 | 0001185185-26-003983 | | 2026-09-10 | 20:10 ET | [8-K](/filings/0001185185-26-003916.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001185185-26-003916 | | 2026-08-28 | 10:52 ET | [DEF 14A](/filings/0001185185-26-003746.md) | Proxy statement, period 2026-10-07 | 0001185185-26-003746 | | 2026-08-05 | 20:15 ET | [8-K](/filings/0001185185-26-003285.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001185185-26-003285 | | 2026-07-30 | 20:59 ET | [SCHEDULE 13D/A](/filings/0000919574-26-004693.md) | Ownership report, active investor, amended | 0000919574-26-004693 | | 2026-07-30 | 20:10 ET | [8-K](/filings/0001185185-26-003177.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-26-003177 | | 2026-07-17 | 22:08 ET | [10-K](/filings/0001185185-26-002997.md) | Annual report, period 2026-04-30 | 0001185185-26-002997 | | 2026-07-15 | 20:10 ET | [8-K](/filings/0001185185-26-002982.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001185185-26-002982 | ## Latest annual report [Form 10-K for the fiscal year ended Apr 30, 2026](/filings/0001185185-26-002997.md), filed Jul 17, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 39020 - Tickers: FEIM - Exchange: Nasdaq - SIC code: 3825 Instruments For Meas & Testing of Electricity & Elec Signals - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.